Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Vaccine    crawled time : 09:36    save search

Vaxart’s COVID-19 Vaccine Selected for the U.S. Government’s Operation Warp Speed
Published: 2020-06-26 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7422 -2.66% -2.74% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 83.55% H: 24.46% C: -30.03%

covid vaccine covid-19
Vaxart Announces IND Filed for COVID-19 Vaccine
Published: 2020-08-10 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7422 -2.66% -2.74% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 4.57% H: 2.6% C: -2.24%

covid vaccine covid-19
Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies
Published: 2020-09-08 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7422 -2.66% -2.74% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 12.37% H: 2.71% C: -13.0%

covid vaccine preclinical response covid-19 pre-clinical
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
Published: 2020-09-14 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7422 -2.66% -2.74% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 20.38% H: 32.76% C: 21.94%

covid fda clearance fda vaccine covid-19 application clearance
Vaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine
Published: 2020-10-13 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7422 -2.66% -2.74% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 5.11% H: 13.77% C: 3.51%

covid vaccine trial phase 3 phase 1 phase 2
Vaxart Announces Positive Hamster Challenge Study Data for its Oral COVID-19 Vaccine
Published: 2020-10-14 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7422 -2.66% -2.74% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.78% H: 2.1% C: -9.33%

covid positive vaccine covid-19
Vaxart Announces Additional Data from Hamster Challenge Study of its Oral COVID-19 Vaccine
Published: 2020-11-12 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7422 -2.66% -2.74% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 12.7% H: 8.86% C: 2.31%

covid vaccine covid-19
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.